Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
The British Journal of Radiology|September 26, 2023
Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgerySarit Appel, Jair Bar, Akram Saad, et al.Translational Oncology|November 13, 2020
Long term follow-up of EGFR mutated NSCLC casesGad Rennert, Maya Gottfried, Hedy S Rennert, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2018
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point InhibitorsElizabeth Dudnik, Nir Peled, Hovav Nechushtan, et al.Clinical Lung Cancer|June 11, 2014
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusionErminia Massarelli, Amir Onn, Edith M Marom, et al.Clinical Lung Cancer|May 8, 2019
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life CohortElizabeth Dudnik, Jair Bar, Nir Peled, et al.Cancer Medicine|March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancerBenjamin Solomon, Ana Callejo, Jair Bar, et al.Journal of Clinical Medicine|June 28, 2023
Timing of Lung Transplant Referral in Patients with Severe COVID-19 Lung Injury Supported by ECMOLiran Levy, Ofir Deri, Ella Huszti, et al.The British Journal of Radiology|March 14, 2019
Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomesSarit Appel, Jair Bar, Alon Ben-Nun, et al.Nature Medicine|April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trialJordi Rodon, Jean-Charles Soria, Raanan Berger, et al.NPJ Precision Oncology|April 29, 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survivalVladimir Lazar, Shai Magidi, Nicolas Girard, et al.Pageof 10